Sign In
Buy TEVA
$32.83
-0.250 (-0.756%)
At Close: Jun 03, 2026
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
04:34pm, Tuesday, 26'th Sep 2023
Drugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5 million jury verdict for Teva Pharmaceutical that found Lilly's migraine drug Emgality infringed three pa
TEVA: A Pharmaceutical Stock to Watch Right Now
10:47am, Tuesday, 12'th Sep 2023
Every week, I am invited on Business First AM with Angela Miles to discuss the market and give a stock pick. This week, I covered TEVA, a stock I have talked about a few times and one, full disclosure
Teva Pharmaceutical Industries Limited (TEVA) Morgan Stanley 21st Annual Global Healthcare Conference 2023 (Transcript)
12:50pm, Monday, 11'th Sep 2023
Teva Pharmaceutical Industries Limited (NYSE:TEVA ) Morgan Stanley 21st Annual Global Healthcare Conference 2023 Call September 11, 2023 8:40 AM ET Company Participants Richard Francis - Chief Executi
Teva to Present at the 21st Annual Morgan Stanley Global Healthcare Conference
04:30pm, Wednesday, 06'th Sep 2023
TEL AVIV, Israel--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at the Morgan Stanley Global H
Alkermes shares surge after settlement with Teva on alcohol dependence treatment
11:27am, Wednesday, 30'th Aug 2023
Shares of Alkermes PLC ALKS, +9.68% jumped 10% Wednesday after the Dublin-based biopharma company announced a settlement of patent litigation with Teva Pharmaceuticals USA Inc. TEVA, relating to Vivit
The Mighty Teva Pharmaceutical: Unveiling A Bullish Scenario You Must Consider
07:43am, Saturday, 26'th Aug 2023
On August 2, Teva Pharmaceutical published its financial report for the second quarter of 2023, which showed an improvement in its financial position. Teva Pharmaceutical's revenue for the second quar
TEVA to Pay $225 Million to Settle Price-Fixing Charges (Revised)
05:16am, Wednesday, 23'rd Aug 2023
TEVA agrees to pay a fine of $225 million over five years per a DPA. Out of this amount, $22.5 million will be due each year from 2024 through 2027 and $135 million will become due in 2028.
TEVA to Pay $250 Million to Settle Price-Fixing Charges
10:31am, Tuesday, 22'nd Aug 2023
TEVA agrees to pay a fine of $225 million over five years per a DPA. Out of this amount, $22.5 million will be due each year from 2024 through 2027 and $135 million will become due in 2028.
Teva Pharma lands US$225 million fine for price-fixing
07:32am, Tuesday, 22'nd Aug 2023
Generic drug maker Teva Pharmaceuticals is to pay US $225 million in fines after admitting price-fixing on a range of drugs in the US. Teva and another firm it worked with, Glenmark Pharmaceuticals, h
Teva to pay $225 million fine and divest cholesterol drug to settle price-fixing charges
05:47pm, Monday, 21'st Aug 2023
Teva Pharmaceuticals agreed to pay more than $200 million in fines and divest a key generic drug treating cholestoral to settle price-fixing charges from the US Department of Justice, the agency annou
DOJ orders Teva and Glenmark to pay millions in fines in drug price fixing settlment
04:47pm, Monday, 21'st Aug 2023
CNBC's Bertha Coombs joins 'Closing Bell Overtime' with breaking news on the DOJ's antitrust agreement involving Teva and Glenmark.
Teva Pharmaceuticals agrees to pay $225 million fine to settle price-fixing charges
04:20pm, Monday, 21'st Aug 2023
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. TEVA, +0.52%, said Monday that it has reached an agreement with the U.S. Department of Justice to settle criminal price-fi
Teva to pay $225 million in fines and divest generic drug to resolve price-fixing charges
04:00pm, Monday, 21'st Aug 2023
It's the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
12:17pm, Friday, 11'th Aug 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to AMPH, RDY and TEVA.
Teva agrees to pay $126 mln to US hospitals over opioids
12:47pm, Thursday, 03'rd Aug 2023
Teva Pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals over 18 years to settle claims that its marketing of opioid drugs raised the hospitals' operating costs.
